REGN
Regeneron Pharmaceuticals Inc
BIOTECHNOLOGY · HEALTHCARE
Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunolo...
$761.85
-1.98% ($15.40)
Volume
1.00M
52W High
$821.11
52W Low
$476.49
Market Cap
$60.54B
What to Watch This Quarter
Based on historical dataConsensus EPS
$5.96
Whisper EPS
$6.52
9.4% above consensus
Last Quarter
$11.44
Current Streak
3 Beats
Avg Surprise (4Q)
+20.19%
Next Earnings Report
Reports in 22 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Jan 30, 2026
5-Day:
+4.53%
Q3 2025
Oct 30, 2025
1-Day:
-0.34%
5-Day:
-3.98%
Q2 2025
Aug 1, 2025
5-Day:
-0.67%
Q1 2025
Apr 29, 2025
1-Day:
+5.25%
Revenue & Financial Performance
Revenue Whisper
$3.68B
TWN Proprietary Estimate
Last Quarter Revenue
$3.88B
+2.5% YoY
Gross Margin
85.0%
Net Margin: 21.7%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $3.88B | +2.5% | 85.0% | 22.7% | $844.6M |
| Q3'25 | $3.75B | +0.9% | 86.1% | 27.4% | $1.46B |
| Q2'25 | $3.68B | +3.6% | 85.6% | 29.4% | $1.39B |
| Q1'25 | $3.03B | -3.7% | 84.7% | 19.5% | $808.7M |
| Q4'24 | $3.79B | +10.3% | 85.1% | 26.1% | $917.7M |
| Q3'24 | $3.72B | +10.7% | 86.8% | 31.7% | $1.34B |
| Q2'24 | $3.55B | +12.3% | 86.5% | 30.2% | $1.43B |
| Q1'24 | $3.15B | -0.5% | 86.2% | 23.9% | $722.0M |
Company Information
Symbol
REGN
Company
Regeneron Pharmaceuticals Inc
Market Cap
$60.54B
Sector
HEALTHCARE
Next Earnings
Apr 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as REGN
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare REGN with competitors
Side-by-side earnings comparison